Literature DB >> 29339324

Oscillatory Synchronous Inhibition in the Basolateral Amygdala and its Primary Dependence on NR2A-containing NMDA Receptors.

Vassiliki Aroniadou-Anderjaska1, Volodymyr I Pidoplichko2, Taiza H Figueiredo3, Maria F M Braga4.   

Abstract

Synchronous, rhythmic firing of GABAergic interneurons is a fundamental mechanism underlying the generation of brain oscillations, and evidence suggests that NMDA receptors (NMDARs) play a key role in oscillatory activity by regulating the activity of interneurons. Consistent with this, derangement of brain rhythms in certain neuropsychiatric disorders, notably schizophrenia and autism, is associated with NMDAR hypofunction and loss of inhibitory interneurons. In the basolateral amygdala (BLA)-dysfunction of which is involved in a host of neuropsychiatric diseases-, principal neurons display spontaneous, rhythmic "bursts" of inhibitory activity, which could potentially be involved in the orchestration of oscillations in the BLA network; here, we investigated the role of NMDARs in these inhibitory oscillations. Rhythmic bursts of spontaneous IPSCs (0.5 Hz average burst frequency) recorded from rat BLA principal cells were blocked or significantly suppressed by D-AP5, and could be driven by NMDAR activation alone. BLA interneurons generated spontaneous bursts of suprathreshold EPSCs at a similar frequency, which were also blocked or reduced by D-AP5. PEAQX (GluN2A-NMDAR antagonist; 0.4 μM) or Ro-25-6981 (GluN2B-NMDAR antagonist; 5 μM) suppressed the IPSC and EPSC bursts; suppression by PEAQX was significantly greater than that by Ro-25-6981. Immunohistochemical labeling revealed the presence of both GluN2A- and GluN2B-NMDARs on GABAergic BLA interneurons, while, functionally, GluN2A-NMDARs have the dominant role, as suggested by a greater reduction of NMDA-evoked currents by PEAQX versus Ro-25-6981. Entrainment of BLA principal neurons in an oscillatory generation of inhibitory activity depends primarily on activation of GluN2A-NMDARs, and interneuronal GluN2A-NMDARs may play a significant role. Published by Elsevier Ltd.

Entities:  

Keywords:  NMDA receptors; NR2A subunit; amygdala; inhibition; interneurons; oscillations

Mesh:

Substances:

Year:  2018        PMID: 29339324     DOI: 10.1016/j.neuroscience.2018.01.021

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Cellular and Molecular Changes in Hippocampal Glutamate Signaling and Alterations in Learning, Attention, and Impulsivity Following Prenatal Nicotine Exposure.

Authors:  Filip S Polli; Theis H Ipsen; Maitane Caballero-Puntiverio; Tina Becher Østerbøg; Susana Aznar; Jesper T Andreasen; Kristi A Kohlmeier
Journal:  Mol Neurobiol       Date:  2020-01-08       Impact factor: 5.590

2.  CPP impairs contextual learning at concentrations below those that block pyramidal neuron NMDARs and LTP in the CA1 region of the hippocampus.

Authors:  Kurt Laha; Mengwen Zhu; Erin Gemperline; Vinuta Rau; Lingjun Li; Michael S Fanselow; Richard Lennertz; Robert A Pearce
Journal:  Neuropharmacology       Date:  2021-10-20       Impact factor: 5.273

3.  Preferential enhancement of GluN2B-containing native NMDA receptors by the endogenous modulator 24S-hydroxycholesterol in hippocampal neurons.

Authors:  Xiaofei Wei; Toshiya Nishi; Shinichi Kondou; Haruhide Kimura; Istvan Mody
Journal:  Neuropharmacology       Date:  2018-12-27       Impact factor: 5.250

4.  Full Protection Against Soman-Induced Seizures and Brain Damage by LY293558 and Caramiphen Combination Treatment in Adult Rats.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Marcio De Araujo Furtado; Maria F M Braga
Journal:  Neurotox Res       Date:  2018-04-30       Impact factor: 3.911

5.  Antiseizure and Neuroprotective Efficacy of Midazolam in Comparison with Tezampanel (LY293558) against Soman-Induced Status Epilepticus.

Authors:  Taiza H Figueiredo; Vassiliki Aroniadou-Anderjaska; Volodymyr I Pidoplichko; James P Apland; Maria F M Braga
Journal:  Toxics       Date:  2022-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.